Overview
John Shern is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland.
Dr. Shern is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Ewing Sarcoma, and Osteosarcoma.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
600 N Wolfe St, Baltimore, MD 21287
Additional Areas of Focus
Dr. Shern has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Johns Hopkins Bayview Medical Center
Patrick Forde is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Forde is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and Small Cell Lung Cancer (SCLC). Dr. Forde is currently accepting new patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.
Office
Brigitte Widemann is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Widemann is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Medullary Thyroid Carcinoma, and Thyroidectomy.
Frequently Asked Questions about Dr. John F. Shern
How do I make an appointment with Dr. John F. Shern?
You can book an appointment with Dr. John F. Shern by calling their office at 410-614-5055. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John F. Shern a top-rated expert for Rhabdomyosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John F. Shern is classified as an Distinguished expert for Rhabdomyosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John F. Shern specialize in?
While Dr. John F. Shern is a Hematology, they have specific expertise in Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, and Ewing Sarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. John F. Shern participate in research or clinical trials?
Yes. Dr. John F. Shern has published 8 articles and abstracts on conditions like Rhabdomyosarcoma. You can view a list of Dr. John F. Shern's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- RhabdomyosarcomaDr. Shern isDistinguished. Learn about Rhabdomyosarcoma.
- Advanced
- Adult Soft Tissue SarcomaDr. Shern isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Ewing SarcomaDr. Shern isAdvanced. Learn about Ewing Sarcoma.
- Experienced
- Embryonal Tumor with Multilayered Rosettes
- FibrosarcomaDr. Shern isExperienced. Learn about Fibrosarcoma.
- Malignant Peripheral Nerve Sheath Tumor
- Medullary Thyroid CarcinomaDr. Shern isExperienced. Learn about Medullary Thyroid Carcinoma.
- NeuroblastomaDr. Shern isExperienced. Learn about Neuroblastoma.
- Neuroendocrine TumorDr. Shern isExperienced. Learn about Neuroendocrine Tumor.
- NeurofibromatosisDr. Shern isExperienced. Learn about Neurofibromatosis.
- OsteosarcomaDr. Shern isExperienced. Learn about Osteosarcoma.
- Thyroid CancerDr. Shern isExperienced. Learn about Thyroid Cancer.
